TopicsAbout
Science, technology and medicine — connected
Sign in
Access2Sciences
Advanced
Access2Sciences

A comprehensive science, technology and medicine content platform for researchers, educators and students — built on trusted editorial standards and open science.

Submit your researchInstitutional access

Publisher

jcd@scientificpublishing.com

37/3 Gadadhar Mistry Lane
Kolkata 700054, India

Discover

  • Browse by Subject
  • Journals
  • Journal Articles
  • eBooks & Chapters
  • Videos & Media

Exam Prep

  • Question Banks
  • Practice Exams
  • Clinical Cases
  • OSCE Stations
  • Curriculum Maps

About

  • About Us
  • Editorial Board
  • Contact
  • For Authors
  • Open Access
  • Submit Article

Account

  • Create Account
  • Sign In
  • My Library
  • Librarian Portal
  • Request Institutional Access
Editorialeditorial@access2sciences.exampleMeet the editorial board →

ISSN 2456-3707

© 2026 Association of Clinical Diabetology · Published by Scientific Publishing. All rights reserved.

Privacy PolicyTerms & ConditionsFAQs
All articles / Journal of Clinical Oncology Practice
⚠

Retracted · 2024-02-01

Retracted due to data integrity concerns identified during post-publication review.

DOI: 10.1000/jcop.2024.retraction-089

Journal of Clinical Oncology Practice · Vol. 11, Issue 4, pp. 210-225

Withdrawn: Novel checkpoint inhibitor combination shows unexpected efficacy

ALL-RIGHTS-RESERVEDDOI: 10.1000/jcop.2023.089Published: Nov 2, 2023

Sign in to save

Abstract

This article has been retracted -- see linked notice.

Full text

Read inline, or switch to the publisher PDF.

Checking access…

Chat with this article

Grounded in this article's full text.

Local model

Ask anything about this article

Every answer cites the passages it came from, so you can check it against the source.

    Runs on your local model — nothing is sent to a third party. Press Enter to send, Shift+Enter for a new line.

    Similar articles

    • Immunotherapy response prediction using multi-omics biomarkers62% match
    • Pioglitazone and Bladder Cancer in India, a Real Threat or Man-Made Fiasco: A Review59% match
    • Metformin beyond Dysglycemia54% match
    • Current Progress with Basal Insulin Analogues54% match

    Citation graph

    References· 0
    This article
    Cited by· 0